Sensorion SA
EPA:ALSEN.PA
Overview | Financials
Company Name | Sensorion SA |
Symbol | ALSEN.PA |
Currency | EUR |
Price | 0.704 |
Market Cap | 211,454,955 |
Dividend Yield | 0% |
52-week-range | 0.403 - 1.04 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Nawal Ouzren |
Website | https://www.sensorion.com |
An error occurred while fetching data.
About Sensorion SA
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD